Celebrity Admissions Spur Weight Loss Medication Telehealth Options
Serena Williams, Andy Cohen, and Meghan Trainor have acknowledged using GLP-1 medications such as Ozempic and Mounjaro for weight management, Page Six reported. Williams shared her experience with the telehealth platform Ro in July 2025, telling People magazine, “I feel great. I feel really good and healthy. I feel light physically and light mentally.”
Following these high-profile disclosures, the telehealth provider Arbor has introduced direct-to-consumer GLP-1 weight loss treatments starting at $99 per month without requiring health insurance. The platform operates as a technology platform connecting patients with independent licensed U.S. providers, according to company details.
Compounded Treatment Offerings and Pricing Structure
Arbor provides two primary compounded GLP-1 treatment options delivered from licensed pharmacies via FedEx Express within approximately two days of approval. Compounded semaglutide costs $99 per month as a once-weekly injection designed to curb cravings and reduce appetite. Compounded tirzepatide costs $149 per month and requires weekly injections to support metabolism alongside appetite control.
Company pricing remains fixed even as patient dosages change. Plan fees cover the medication, dose adjustments, consultations, and ongoing check-ins without additional surcharges. Patients initiate the process through a 90-second online health quiz with no waitlist.
Telehealth Access and Guarantee Terms
The telehealth service eliminates in-person doctor visits by utilizing virtual prescriptions from licensed U.S. physicians. Both treatment plans qualify for Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs), and patients retain the option to cancel subscriptions at any time.
Arbor backs its programs with a 12-month money-back guarantee for customers unsatisfied with their results. The platform also provides round-the-clock physician access and support from registered dietitians. The company notes that independent licensed providers conduct all medical evaluations to determine treatment eligibility, and compounded medications do not undergo FDA review for safety and effectiveness.
Keep reading